Infectious Diseases

Infectious Diseases

Shimadzu has positioned countermeasures against infectious diseases as a major social issue. In addition to the existing lineup of instruments and reagents, we make an effort further to develop new products. We are also actively cooperating with universities, hospitals, and medical institutions, to create new approaches to infectious disease countermeasures. Our efforts are based on two perspectives: prevention of the further spread of COVID-19, and countermeasures for infectious diseases as a whole, with an eye to subsequent new risks.

Virus Testing

Novel Coronavirus Detection Reagent Kit

Novel Coronavirus Detection Reagent Kit

Enables PCR Detection in 70 Minutes with Simple Pretreatment

As compared to regular kits, this detection kit eliminates the need for RNA extraction and purification and halves the overall time required for PCR detection.

(*) The kit (Research Use Only) is only available in Japan.

Multiple Simultaneous Pathogen Gene Detection

Multiple Simultaneous Pathogen Gene Detection System

Simultaneous Detection of Multiple Genes Related to Viruses and Bacteria Responsible for Infectious Diseases

 

(*) The above systems are only available in Japan.

Pathology Diagnosis

Mobile Digital X-ray Systems (Pneumonia Diagnosis)

Mobile X-ray Systems (Pneumonia Tests)

Enables Bedside Pneumonia Diagnosis in Hospital Wards and ICUs

 
  • Advanced Image Processing
  • Strengthened Network Systems
  • Virus Removal Using Optical Technologies

Accuracy Controls for Testing/Preventing Infections

Infection Countermeasures Network

Infection Countermeasures Network
  • Automated Reception System Reduces Infection Risks in Hospitals
  • Virus Monitoring: Monitoring coronaviruses in sewer water to predict virus spread

(*) The above systems are only available in Japan.

Supporting the Clinical Research for Therapeutic Drugs

System for Measuring the Blood Concentration of Therapeutic Drug Candidates for COVID-19

Monitoring can be performed with an LCMS system using stable isotope reagents (internal standards) for blood concentration measurements of therapeutic drug candidates for COVID-19.

PCR Testing in 70 Minutes with Simple Pretreatment

Research Use Only. Not for Use in Diagnostic Procedures.

In addition to providing products, Shimadzu is working with universities, hospitals, and medical institutions to create a countermeasure system to combat infectious diseases.